Grade My Investments
HomeFree Stock Grades › STAA

STAAR Surgical Company (STAA) Stock Grade

STAA · Healthcare

C-
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$1.2B
P/E Ratio
Revenue Growth (YoY)
-23.7%
Net Margin
-33.6%
Return on Equity
Dividend Yield
None

About STAAR Surgical Company's fundamentals

STAAR Surgical reported a net loss in its latest annual statement, resulting in a negative net margin of -33.6%. The company experienced significant revenue contraction, with year-over-year revenue declining 23.7%, indicating substantial headwinds in its medical devices business. With a market capitalization of $1.2 billion and no dividend payment, the company is unprofitable and reinvesting all available resources rather than returning capital to shareholders.

Track STAA free — no credit card required. Live grade + monthly AI report →